We propose to build a collaborative database of Genome-Wide Association Studies (GWAS) of breast cancer with over 15,000 cases of European ancestry, and appropriate controls, and impute >2.5 million imputed HapmapS SNPs for these cases and controls. We will then rank all genotyped and imputed SNPs based their P values for association with (a) total breast cancer (b) breast cancer at age <50 (primarily based on 3,200 cases and 3,200 controls scanned in the Breast Cancer Family Registry (BCFR)) and (c) women with ER-negative breast cancer (primarily based on 1,600 cases and 1,600 controls scanned in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) Based on these results we will perform replication studies in two large-scale Consortia (a) cohorts in the BCP3 and (b) case-control studies in the Breast Cancer Association Consortium (BCAC). In the BPC3 we propose to expand the current six component cohorts (13,500 cases and an equal number of controls) by collaborating with the Women's Health Initiative (4,500 cases and 4,500 controls) to increase the BPC3 sample size to 18,000 cases and 18,000 controls. To narrow the interval of linkage disequilibrium observed at each locus we will collaborate with large pooled GWAS of breast cancer in women with African ancestry (n=2,500 cases and 2,500 controls) and Asian ancestry (n=3,500 cases and 3,500 controls). Building on this trans-ethnic collaborative effort and on the resequencing data from the 1,000 Genomes Project, we will choose SNPs for fine mapping of the loci identified in the previous aims, in 10,000 further European ancestry cases and 10,000 controls, and an additional 3,500 Asian cases and 3,500 controls, in order to narrow the number of variants for which evidence of function will be sought in sub-Project 2.

Public Health Relevance

This project will aid in the systematic discovery and replication of germline genetic variants that are associated with risk of breast cancer. Initially a genetic locus will be identified, and then from a large number of variants at the locus, one or a small number of variants with the strongest associations will be identified. These can be investigated in Project 2 of this proposal and may eventually lead to better prevention and treatment strategies for breast cancer, which is expected to kill over 40,000 U.S. women in 2009. These variants will also be examined for gene-gene interaction, gene-environment interaction, and their contribution to risk prediction algorithms in Project 3.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA148065-04
Application #
8549156
Study Section
Special Emphasis Panel (ZCA1-SRLB-4)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
4
Fiscal Year
2013
Total Cost
$1,340,385
Indirect Cost
$158,632
Name
Harvard University
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Hatzis, Christos; Bedard, Philippe L; Birkbak, Nicolai J et al. (2014) Enhancing reproducibility in cancer drug screening: how do we move forward? Cancer Res 74:4016-23
Lindström, Sara; Thompson, Deborah J; Paterson, Andrew D et al. (2014) Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nat Commun 5:5303
Joshi, Amit D; Lindström, Sara; Hüsing, Anika et al. (2014) Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 180:1018-27
Prentice, Ross L (2014) Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Semin Reprod Med 32:419-25
Milne, Roger L; Burwinkel, Barbara; Michailidou, Kyriaki et al. (2014) Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Hum Mol Genet 23:6096-111
Li, Jingmei; Lindström, Linda S; Foo, Jia N et al. (2014) 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. Nat Commun 5:4051
Li, Qiyuan; Stram, Alexander; Chen, Constance et al. (2014) Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types. Hum Mol Genet 23:5294-302
Meng, Chen; Kuster, Bernhard; Culhane, Aedín C et al. (2014) A multivariate approach to the integration of multi-omics datasets. BMC Bioinformatics 15:162
Cai, Qiuyin; Zhang, Ben; Sung, Hyuna et al. (2014) Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. Nat Genet 46:886-90
Milne, Roger L; Herranz, Jesus; Michailidou, Kyriaki et al. (2014) A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 23:1934-46

Showing the most recent 10 out of 37 publications